학술논문
S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROME
Document Type
article
Source
HemaSphere, Vol 7, p e684700a (2023)
Subject
Language
English
ISSN
2572-9241